Journal of Alzheimers Disease

Article	Citations
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	123
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	120
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	116
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	114
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	107
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	106
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	91
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	86
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	83
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	78
White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults	78
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	74
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1	69
Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease	66
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	65
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease	65
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	64
Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding	62
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	62
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	61
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	59
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	55
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan	54
A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders	52
Fluid Biomarkers in Clinical Trials for Alzheimer’s Disease: Current and Future Application	52

Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	51
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	50
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	50
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia	50
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	48
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	48
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	46
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	46
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	44
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	44
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder	44
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	44
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	43
Incident Dementia After Spontaneous Intracerebral Hemorrhage	42
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	41
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	41
Attentional Control in Subjective Cognitive Decline	41
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	40
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	40
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	40
Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study	40
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	39
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	39
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	38
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging	37
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	37
Current and Future Directions for Targeting Lipoxin A4 in Alzheimer’s Disease	36
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	36
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	36
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	36
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	36
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	35
Cerebral Microbleeds Are Associated with Impairments in Executive Function and Processing Speed	34
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	34
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	34
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	34
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	34
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	34
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction	34
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	33
Implication of Small Vessel Disease MRI Markers in Alzheimer’s Disease and Lewy Body Disease1	33
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	32
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	32
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	32
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	32
Methylcobalamin Alleviates Neuronal Apoptosis and Cognitive Decline Induced by PM2.5 Exposure in Mice	32
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	32
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	32
Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy	31
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	31

A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease	31
Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study	31
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	31
Hydrate to keep the amyloid away	30
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	30
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	30
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	30
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	30
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	30
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	29
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	29
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	29
Screening for Early-Stage Alzheimer’s Disease Using Optimized Feature Sets and Machine Learning	29
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	29
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	29
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	29
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	29
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	29
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	28
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	28
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	28
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols	28
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease	28
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	28
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	28
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	27
The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review	27
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	27
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014)	27
Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer’s Disease	27
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	27
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	27
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	27
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	27
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	27
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	27
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	26
Cross-Cultural Comparisons of Subjective Cognitive Complaints in a Diverse Primary Care Population	26
The Characteristics of Social Network Structure in Later Life in Relation to Incidence of Mild Cognitive Impairment and Conversion to Probable Dementia	26
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	26
COVID-19 and Alzheimer’s Disease: What Is the Connection?	26
Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer’s Di	26
Efficacy of a Virtual Education Program for Family Caregivers of Persons Living with Dementia	26
Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System	26
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	26
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	26
Segmented Linear Mixed Model Analysis Reveals Association of the APOE ɛ4 Allele with Faster Rate of Alzheimer’s Disease Dementia Progression	26
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	26
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	26
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function	26
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	26
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	26
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	25
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	25
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	25
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition	25
Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study	25
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	25
The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET prediction	25
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	25
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	24
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	24
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	24
The Diagnostic Value of a Short Memory Test: The TNI-93	24
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	24
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	24
Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study	24
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	24
Supporting and Protecting People with Dementia in the COVID-19 Pandemic	24
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	24
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	24
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	24
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	24
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	24
Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer’s Disease	24
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	24
Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer’s Disease and Cognitive Function	23
Latent Profile Analysis of Cognition in a Non-Demented Diverse Cohort: A Focus on Modifiable Cardiovascular and Lifestyle Factors	23
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	23
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	23

Developing an Image-Based Deep Learning Framework for Automatic Scoring of the Pentagon Drawing Test	23
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	23
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	23
No Influence of Age-Related Hearing Loss on Brain Amyloid-β	23
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	23
Causes of Death in People with Dementia from 2002 to 2015: A Nationwide Study	23
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	23
Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies	22
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	22
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	22
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	22
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentratio	22
Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study	22
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	22
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	22
Classifying Non-Dementia and Alzheimer’s Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test	22
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	22
Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study	22
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	22
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	22
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	22
A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents	22
Digital Technology Differentiates Graphomotor and Information Processing Speed Patterns of Behavior	21
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	21
From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery	21
The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer’s Disease	21
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition	21
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	21
CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) Neuropsychology Assessment Battery: 35 Years and Counting	21
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease	21
A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data	21
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	21
RETRACTED: Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind,	21
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	21
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	21
Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice	21
Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults	21
Physical Activity and Cognition in Sedentary Older Adults: A Systematic Review and Meta-Analysis	21
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease	21
Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer’s Disease	21
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?	21
Meaning in life and neurobiomarkers of brain health in the UK Biobank	21
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	21
Societal Costs of Dementia: 204 Countries, 2000–2019	21
Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer’s Disease: A Phase II Double-Blind Placebo-Controlled Trial	21
Towards characterizing subjective cognitive decline in older adults	21
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	21
Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging	21
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease	21
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	20
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	20
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer’s Disease Pathology	20
Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study	20
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	20
Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabùt Aging Project	20
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay	20
New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity	20
The Use of Serum Matrix Metalloproteinases in Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage and Cognitive Impairment	20
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation	20
Loneliness, Dementia Status, and Their Association with All-Cause Mortality Among Older US Adults	20
Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease	20
Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer’s Disease	20
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	20
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment	20
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome	20
Phonological and Semantic Fluency in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	20
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study	20
Hippocampal-Subregion Mechanisms of Repetitive Transcranial Magnetic Stimulation Causally Associated with Amelioration of Episodic Memory in Amnestic Mild Cognitive Impairment	20
Association of Plastic Exposure with Cognitive Function Among Chinese Older Adults	19
Factors Associated with Cognitive Outcomes After First-Ever Ischemic Stroke: The Impact of Small Vessel Disease Burden and Neurodegeneration	19
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia	19
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries	19
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	19
Diffusion Imaging of Gray Matter Microstructure in Alzheimer’s Disease	19
Dementia Knowledge, Attitude toward Dementia, and Confidence in Dementia Care: Impact of a Dementia Training on German Nursing Students	19
Systolic Blood Pressure and Cognition in the Elderly: The Northern Manhattan Study1	19
Identification of Major Cognitive Disorders in Self-Reported versus Administrative Health Data: A Cohort Study in Quebec	19
3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation	19
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer’s Disease	19
Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer’s Disease and Argyrophilic Grain Disease	19
Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)	19
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	19
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	19
A Longitudinal Study of Functional Unmet Need Among People with Dementia	19
A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies	19
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	19
Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment	18
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	18
The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study	18
Cross-Sectional Examination of Homocysteine Levels with Sarcopenia and Its Components in Memory Clinic Outpatients	18
Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer’s Disease	18
Toward Pre-Diagnostic Detection of Dementia in Primary Care	18
Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review	18
Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life	18
Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro	18